Genetic Variants and Cognitive Functions in Patients with Brain Tumors.
暂无分享,去创建一个
J. Satagopan | D. Correa | L. Deangelis | J. Lyo | S. Karimi | I. Orlow | Sofia Dimitriadoy | S. Leong | K. O'Connell | M. Kryza-Lacombe | K. Cheung | Axel Martin | E. Braun | Ajay Sharma | Erica Braun | Sofia G. Dimitriadoy | Siok F Leong
[1] J. Dietrich,et al. Pharmacologic management of cognitive impairment induced by cancer therapy. , 2019, The Lancet. Oncology.
[2] Nilanjan Chatterjee,et al. Estimation of complex effect-size distributions using summary-level statistics from genome-wide association studies across 32 complex traits , 2018, Nature Genetics.
[3] D. Bennett,et al. A dopamine receptor genetic variant enhances perceptual speed in cognitive healthy subjects , 2017, Alzheimer's & dementia.
[4] Ye Xu,et al. A Comprehensive Meta-analysis of Genetic Associations Between Key Polymorphic Loci in DNA Repair Genes and Glioma Risk , 2017, Molecular Neurobiology.
[5] Yvonne Brehmer,et al. Dopamine Receptor Genes Modulate Associative Memory in Old Age , 2017, Journal of Cognitive Neuroscience.
[6] J. Satagopan,et al. COMT, BDNF, and DTNBP1 polymorphisms and cognitive functions in patients with brain tumors. , 2016, Neuro-oncology.
[7] Feifei Pu,et al. Association between a functional variant in RAD51 gene’s 3′ untranslated region and its mRNA expression in lymphoblastoid cell lines , 2016, SpringerPlus.
[8] Paul Edison,et al. Neuroinflammation in Alzheimer's disease: Current evidence and future directions , 2016, Alzheimer's & Dementia.
[9] Nathaniel Rothman,et al. Bayes and empirical Bayes methods for reduced rank regression models in matched case‐control studies , 2016, Biometrics.
[10] J. Bainbridge,et al. Current and emerging treatment of multiple sclerosis. , 2016, The American journal of managed care.
[11] Kyle R. Noll,et al. Neurocognitive functioning and genetic variation in patients with primary brain tumours. , 2016, The Lancet. Oncology.
[12] E. Zaslavsky,et al. Astrocytic TYMP and VEGFA drive blood-brain barrier opening in inflammatory central nervous system lesions. , 2015, Brain : a journal of neurology.
[13] M. Gilbert,et al. Genetic Modulation of Neurocognitive Function in Glioma Patients , 2015, Clinical Cancer Research.
[14] J. Satagopan,et al. APOE polymorphisms and cognitive functions in patients with brain tumors , 2014, Neurology.
[15] M. Rietschel,et al. DRD2/ANKK1 Polymorphism Modulates the Effect of Ventral Striatal Activation on Working Memory Performance , 2014, Neuropsychopharmacology.
[16] Christopher T. Smith,et al. Genetic Polymorphisms Regulating Dopamine Signaling in the Frontal Cortex Interact to Affect Target Detection under High Working Memory Load , 2014, Journal of Cognitive Neuroscience.
[17] Nick C Fox,et al. Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease , 2013, Nature Genetics.
[18] Cheng Cheng,et al. Genetic mediators of neurocognitive outcomes in survivors of childhood acute lymphoblastic leukemia. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[19] Y. Pi,et al. Association between interleukin-1α C(−889)T polymorphism and Alzheimer’s disease: a meta-analysis including 12,817 subjects , 2013, Journal of Neural Transmission.
[20] J. Thariat,et al. The impact of pharmacogenetics on radiation therapy outcome in cancer patients. A focus on DNA damage response genes. , 2012, Cancer Treatment Reviews.
[21] Suyun Huang,et al. FoxM1 Inhibition Sensitizes Resistant Glioblastoma Cells to Temozolomide by Downregulating the Expression of DNA-Repair Gene Rad51 , 2012, Clinical Cancer Research.
[22] Eurie L. Hong,et al. Annotation of functional variation in personal genomes using RegulomeDB , 2012, Genome research.
[23] Jason J. Corneveaux,et al. A genome-wide scan for common variants affecting the rate of age-related cognitive decline , 2012, Neurobiology of Aging.
[24] Richard Mayeux,et al. Impact of Genetic Variation in SORCS1 on Memory Retention , 2011, PloS one.
[25] M. D’Esposito,et al. Inverted-U–Shaped Dopamine Actions on Human Working Memory and Cognitive Control , 2011, Biological Psychiatry.
[26] Christophe Badie,et al. Gene expression following ionising radiation: Identification of biomarkers for dose estimation and prediction of individual response , 2011, International journal of radiation biology.
[27] J. Haines,et al. SORCS1 alters amyloid precursor protein processing and variants may increase Alzheimer's disease risk , 2011, Annals of neurology.
[28] B. Elvevåg,et al. Genes, cognition and brain through a COMT lens , 2009, Neuroscience.
[29] B. Efron. Empirical Bayes Estimates for Large-Scale Prediction Problems , 2009, Journal of the American Statistical Association.
[30] D. Rowitch,et al. Dysregulation of the Wnt pathway inhibits timely myelination and remyelination in the mammalian CNS. , 2009, Genes & development.
[31] R. Rudick,et al. LINGO-1 antagonists as therapy for multiple sclerosis: in vitro and in vivo evidence , 2008, Expert opinion on biological therapy.
[32] D. Chistiakov,et al. Genetic variations in DNA repair genes, radiosensitivity to cancer and susceptibility to acute tissue reactions in radiotherapy-treated cancer patients , 2008, Acta oncologica.
[33] M. Kelley,et al. DNA repair in neurons: so if they don't divide what's to repair? , 2007, Mutation research.
[34] P. Bickford,et al. Selective decline of Nogo mRNA in the aging brain , 2006, Neuroreport.
[35] Thomas E. Nichols,et al. Impact of complex genetic variation in COMT on human brain function , 2006, Molecular Psychiatry.
[36] P. Brown,et al. Role and relevance of neurocognitive assessment in clinical trials of patients with CNS tumors. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[37] Zhigang He,et al. A TNF Receptor Family Member, TROY, Is a Coreceptor with Nogo Receptor in Mediating the Inhibitory Activity of Myelin Inhibitors , 2005, Neuron.
[38] T. Goldberg,et al. Genes and the parsing of cognitive processes , 2004, Trends in Cognitive Sciences.
[39] J. Relton,et al. LINGO-1 is a component of the Nogo-66 receptor/p75 signaling complex , 2004, Nature Neuroscience.
[40] Claudio Franceschi,et al. Interleukin-6 gene alleles affect the risk of Alzheimer’s disease and levels of the cytokine in blood and brain , 2003, Neurobiology of Aging.
[41] Sylvia Richardson,et al. Markov Chain Monte Carlo in Practice , 1997 .
[42] H. Sandler. Side effects of radiation therapy. , 1991, American family physician.
[43] A. Alavi,et al. MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging. , 1987, AJR. American journal of roentgenology.
[44] S. Rosso,et al. Vitamin D receptor polymorphisms and survival in patients with cutaneous melanoma: a population-based study. , 2016, Carcinogenesis.
[45] S. Rosso,et al. Vitamin D receptor polymorphisms and survival in patients with cutaneous melanoma: A population-based study. , 2015, Carcinogenesis.
[46] M. Rietschel,et al. DRD 2 / ANKK 1 Polymorphism Modulates the Effect of Ventral Striatal Activation on Working Memory Performance , 2014 .
[48] O. Okonkwo,et al. Interaction between two cholesterol metabolism genes influences memory: findings from the Wisconsin Registry for Alzheimer's Prevention. , 2013, Journal of Alzheimer's disease : JAD.
[49] A. Sandrock,et al. LINGO-1 and its role in CNS repair. , 2008, The international journal of biochemistry & cell biology.
[50] Nick Orr,et al. Common genetic variation and human disease. , 2008, Advances in genetics.
[51] W. Sturm,et al. Neuropsychological assessment , 2007, Journal of Neurology.
[52] Martyn Plummer,et al. JAGS: A program for analysis of Bayesian graphical models using Gibbs sampling , 2003 .
[53] D. Comings,et al. Reward deficiency syndrome: genetic aspects of behavioral disorders. , 2000, Progress in brain research.